TELA Bio board changes: Lisa Colleran resigns, Dr. Betty Jo Rocchio appointed

TELA Bio, Inc.

Lisa Colleran resigned from the board on Oct 4, 2025; no disagreement with company.
Dr. Betty Jo Rocchio appointed effective Oct 9, 2025; she is EVP, Chief Executive Nurse at Advocate Health.
Initial equity award: option for 17,550 shares vesting monthly over 3 years; RSU for 11,925 shares vesting annually over 3 years.
Annual retainer $45,000; starting 2026: annual award of option for 11,700 shares and RSU for 7,950 shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.